Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Identification of Candidate...
    Kia, Demis A; Zhang, David; Guelfi, Sebastian; Manzoni, Claudia; Hubbard, Leon; Reynolds, Regina H; Botía, Juan; Ryten, Mina; Ferrari, Raffaele; Lewis, Patrick A; Williams, Nigel; Trabzuni, Daniah; Hardy, John; Wood, Nicholas W

    JAMA neurology, 04/2021, Letnik: 78, Številka: 4
    Journal Article

    IMPORTANCE: Substantial genome-wide association study (GWAS) work in Parkinson disease (PD) has led to the discovery of an increasing number of loci shown reliably to be associated with increased risk of disease. Improved understanding of the underlying genes and mechanisms at these loci will be key to understanding the pathogenesis of PD. OBJECTIVE: To investigate what genes and genomic processes underlie the risk of sporadic PD. DESIGN AND SETTING: This genetic association study used the bioinformatic tools Coloc and transcriptome-wide association study (TWAS) to integrate PD case-control GWAS data published in 2017 with expression data (from Braineac, the Genotype-Tissue Expression GTEx, and CommonMind) and methylation data (derived from UK Parkinson brain samples) to uncover putative gene expression and splicing mechanisms associated with PD GWAS signals. Candidate genes were further characterized using cell-type specificity, weighted gene coexpression networks, and weighted protein-protein interaction networks. MAIN OUTCOMES AND MEASURES: It was hypothesized a priori that some genes underlying PD loci would alter PD risk through changes to expression, splicing, or methylation. Candidate genes are presented whose change in expression, splicing, or methylation are associated with risk of PD as well as the functional pathways and cell types in which these genes have an important role. RESULTS: Gene-level analysis of expression revealed 5 genes (WDR6 OMIM 606031, CD38 OMIM 107270, GPNMB OMIM 604368, RAB29 OMIM 603949, and TMEM163 OMIM 618978) that replicated using both Coloc and TWAS analyses in both the GTEx and Braineac expression data sets. A further 6 genes (ZRANB3 OMIM 615655, PCGF3 OMIM 617543, NEK1 OMIM 604588, NUPL2 NCBI 11097, GALC OMIM 606890, and CTSB OMIM 116810) showed evidence of disease-associated splicing effects. Cell-type specificity analysis revealed that gene expression was overall more prevalent in glial cell types compared with neurons. The weighted gene coexpression performed on the GTEx data set showed that NUPL2 is a key gene in 3 modules implicated in catabolic processes associated with protein ubiquitination and in the ubiquitin-dependent protein catabolic process in the nucleus accumbens, caudate, and putamen. TMEM163 and ZRANB3 were both important in modules in the frontal cortex and caudate, respectively, indicating regulation of signaling and cell communication. Protein interactor analysis and simulations using random networks demonstrated that the candidate genes interact significantly more with known mendelian PD and parkinsonism proteins than would be expected by chance. CONCLUSIONS AND RELEVANCE: Together, these results suggest that several candidate genes and pathways are associated with the findings observed in PD GWAS studies.